Cingulate Therapeutics
Jennifer Callahan has been with Cingulate Inc. since January 2019, currently holding the position of SVP, Chief Financial Officer. Prior to this, Jennifer worked at Heritage Omaha since May 1999 as the Treasurer and Controller. Before that, Jennifer was at Tarsus from March 2014 to February 2019 as a Consultant/Controller Services. Jennifer also served as the Director of Accounting at Meridian Business Services LLC from March 2014 to March 2017. Jennifer started their career at Deloitte from June 1992 to December 1998 as an Audit Manager. Jennifer graduated from Creighton University in 1992 with a BSBA in Accounting and Finance.
This person is not in any teams
Cingulate Therapeutics
1 followers
Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.